Biosino Bio-Technology and Science (HKSE:08247) Total Liabilities : HK$363.0 Mil (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Biosino Bio-Technology and Science Total Liabilities?

Biosino Bio-Technology and Science's Total Liabilities for the quarter that ended in Dec. 2023 was HK$363.0 Mil.

Biosino Bio-Technology and Science's quarterly Total Liabilities declined from Jun. 2023 (HK$384.18 Mil) to Sep. 2023 (HK$0.00 Mil) but then increased from Sep. 2023 (HK$0.00 Mil) to Dec. 2023 (HK$362.97 Mil).

Biosino Bio-Technology and Science's annual Total Liabilities declined from Dec. 2021 (HK$500.01 Mil) to Dec. 2022 (HK$412.22 Mil) and declined from Dec. 2022 (HK$412.22 Mil) to Dec. 2023 (HK$362.97 Mil).

Biosino Bio-Technology and Science Total Liabilities Historical Data

The historical data trend for Biosino Bio-Technology and Science's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosino Bio-Technology and Science Total Liabilities Chart

Biosino Bio-Technology and Science Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

496.00

507.77

500.01

412.22

362.97

Biosino Bio-Technology and Science Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															412.22	-	384.18	-	362.97

Biosino Bio-Technology and Science Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biosino Bio-Technology and Science's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	350.826	+	(5.985	+	6.156
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	363.0

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	616.072	-	253.105
	=	363.0

Biosino Bio-Technology and Science's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	350.826	+	(5.985	+	6.156
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	363.0

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	616.072	-	253.105
	=	363.0

Biosino Bio-Technology and Science Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biosino Bio-Technology and Science's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosino Bio-Technology and Science (HKSE:08247) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biosino Bio-Technology and Science Inc (HKSE:08247) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 27 Chaoqian Road, Science and Technology Industrial Park, Changping District, Beijing, CHN, 102200

Website

http://www.zhongsheng.com.cn

Biosino Bio-Technology and Science Inc is engaged in the manufacture, sale, and distribution of in-vitro diagnostic (IVD) reagent products. the company's revenue is generated from customers located in Mainland China.

Executives

Beijing Enterprises Group Company Limited	2201 Interest of corporation controlled by you
Beijing Enterprises Holdings Limited	2101 Beneficial owner
Hk Zhixin Investment Co., Ltd.	2101 Beneficial owner
Li Dongfeng	2201 Interest of corporation controlled by you
Yan Kang	2201 Interest of corporation controlled by you
Qiu Zhe Feng	2201 Interest of corporation controlled by you
Hai Nan Zhi Xin Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Yun Nan Sheng Neng Tou Zi He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Li Yang Yi Xiong	2201 Interest of corporation controlled by you

Biosino Bio-Technology and Science (HKSE:08247) Headlines

No Headlines